Martin Tami Tillotson — SEC Form 4 filings

SEC reporting owner CIK 1539494. 3 Form 4 filings on record with FilingPulse; latest filed 2024-02-27.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-12 to 2024-02-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SUPERNUS PHARMACEUTICALS, INC. (SUPN)Sr. V.P., Regulatory Affairs31 leg · 8,000 sh · $223,2808

Form 4 filings — Martin Tami Tillotson

FiledFormIssuerReported transactionsSource
2024-02-274SUPERNUS PHARMACEUTICALS, INC. (SUPN)Grant/award (A): 1,250 @ $0 · Tax withholding (F): 485 @ $29.06 · Disposition to issuer (D): 1,250 (derivative) @ $0EDGAR
2024-02-264SUPERNUS PHARMACEUTICALS, INC. (SUPN)Grant/award (A): 750 @ $0 · Tax withholding (F): 246 @ $27.94 · Disposition to issuer (D): 750 (derivative) @ $0EDGAR
2024-01-124SUPERNUS PHARMACEUTICALS, INC. (SUPN)Option exercise (M): 8,000 @ $9.24 · Sale (S): 8,000 @ $27.91 · Option exercise (M): 8,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1539494 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →